{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T11:08:31Z","timestamp":1784977711298,"version":"3.55.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intensive Care Med"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1007\/s00134-022-06967-9","type":"journal-article","created":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T11:42:45Z","timestamp":1675251765000},"page":"291-301","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Epidemiology, clinical presentation, and outcomes of 620 patients with eosinophilia in the intensive care unit"],"prefix":"10.1007","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0742-2348","authenticated-orcid":false,"given":"Antoine","family":"Gaillet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Bay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwige","family":"P\u00e9ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hafid","family":"Ait-Oufella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elie","family":"Azoulay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nacime","family":"Benchabane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Cerf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"de Prost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanislas","family":"Faguer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Geri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Grang\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Emmanuel","family":"Kahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Kreitmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romaric","family":"Larcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Lef\u00e8vre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asma","family":"Mabrouki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armand","family":"Mekonsto-Dessap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kewin","family":"Panel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"P\u00e8ne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Pineton de Chambrun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Quenot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yacine","family":"Tandjaoui-Lambiotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Francois","family":"Timsit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Vieillard-Baron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Auguste","family":"Dargent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Herault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Groh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,1]]},"reference":[{"key":"6967_CR1","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3389\/fmed.2017.00101","volume":"4","author":"T Marichal","year":"2017","unstructured":"Marichal T, Mesnil C, Bureau F (2017) Homeostatic eosinophils: characteristics and functions. Front Med (Lausanne) 4:101. https:\/\/doi.org\/10.3389\/fmed.2017.00101","journal-title":"Front Med (Lausanne)"},{"issue":"11","key":"6967_CR2","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1182\/blood-2012-05-432088","volume":"121","author":"S Ueki","year":"2013","unstructured":"Ueki S, Melo RCN, Ghiran I et al (2013) Eosinophil extracellular DNA trap cell death mediates lytic release of free secretion-competent eosinophil granules in humans. Blood 121(11):2074\u20132083. https:\/\/doi.org\/10.1182\/blood-2012-05-432088","journal-title":"Blood"},{"issue":"9","key":"6967_CR3","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1182\/blood-2014-11-551614","volume":"126","author":"AD Klion","year":"2015","unstructured":"Klion AD (2015) How I treat hypereosinophilic syndromes. Blood 126(9):1069\u20131077. https:\/\/doi.org\/10.1182\/blood-2014-11-551614","journal-title":"Blood"},{"issue":"6","key":"6967_CR4","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1016\/j.jaci.2009.09.022","volume":"124","author":"PU Ogbogu","year":"2009","unstructured":"Ogbogu PU, Bochner BS, Butterfield JH et al (2009) Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy. J Allergy Clin Immunol 124(6):1319\u201325.e3. https:\/\/doi.org\/10.1016\/j.jaci.2009.09.022","journal-title":"J Allergy Clin Immunol"},{"issue":"19","key":"6967_CR5","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1016\/j.jacc.2017.09.023","volume":"70","author":"M Brambatti","year":"2017","unstructured":"Brambatti M, Matassini MV, Adler ED (2017) Eosinophilic myocarditis: characteristics, treatment, and outcomes. J Am Coll Cardiol 70(19):2363\u20132375. https:\/\/doi.org\/10.1016\/j.jacc.2017.09.023","journal-title":"J Am Coll Cardiol"},{"key":"6967_CR6","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.121.034191","author":"J Tennenbaum","year":"2021","unstructured":"Tennenbaum J, Groh M, Venditti L et al (2021) FIP1L1-PDGFRA-associated hypereosinophilic syndrome as a treatable cause of watershed infarction. Stroke. https:\/\/doi.org\/10.1161\/STROKEAHA.121.034191","journal-title":"Stroke"},{"issue":"9","key":"6967_CR7","doi-asserted-by":"publisher","first-page":"3497","DOI":"10.1016\/j.jaip.2021.04.067","volume":"9","author":"M Groh","year":"2021","unstructured":"Groh M, Pineton de Chambrun M, Georges JL et al (2021) Recurrent cardiac arrest due to eosinophilia-related coronary vasospasm successfully treated by benralizumab. J Allergy Clin Immunol Pract 9(9):3497-3499.e1. https:\/\/doi.org\/10.1016\/j.jaip.2021.04.067","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"6967_CR8","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.jaci.2012.02.019","volume":"130","author":"P Valent","year":"2012","unstructured":"Valent P, Klion A, Horny H et al (2012) Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes. J Allergy Clin Immunol 130(3):607-612.e9. https:\/\/doi.org\/10.1016\/j.jaci.2012.02.019","journal-title":"J Allergy Clin Immunol"},{"issue":"1\u20132","key":"6967_CR9","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s12016-011-8274-y","volume":"43","author":"S Louie","year":"2011","unstructured":"Louie S, Morrissey BM, Kenyon NJ, Albertson TE, Avdalovic M (2011) The critically ill asthmatic\u2014from ICU to discharge. Clin Rev Allergy Immunol 43(1\u20132):30\u201344. https:\/\/doi.org\/10.1007\/s12016-011-8274-y","journal-title":"Clin Rev Allergy Immunol"},{"issue":"6","key":"6967_CR10","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s15010-015-0799-1","volume":"43","author":"G Geri","year":"2015","unstructured":"Geri G, Rabbat A, Mayaux J et al (2015) Strongyloides stercoralis hyperinfection syndrome: a case series and a review of the literature. Infection 43(6):691\u2013698. https:\/\/doi.org\/10.1007\/s15010-015-0799-1","journal-title":"Infection"},{"issue":"1","key":"6967_CR11","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13054-014-0722-7","volume":"19","author":"FS Taccone","year":"2015","unstructured":"Taccone FS, Van den Abeele AM, Bulpa P et al (2015) Epidemiology of invasive aspergillosis in critically ill patients: clinical presentation, underlying conditions, and outcomes. Crit Care 19(1):7. https:\/\/doi.org\/10.1186\/s13054-014-0722-7","journal-title":"Crit Care"},{"issue":"5","key":"6967_CR12","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1097\/SHK.0000000000000041","volume":"40","author":"A Kimmoun","year":"2013","unstructured":"Kimmoun A, Dubois E, Perez P et al (2013) Shock state: an unrecognized and underestimated presentation of drug reaction with eosinophilia and systemic symptoms. Shock 40(5):387\u2013391. https:\/\/doi.org\/10.1097\/SHK.0000000000000041","journal-title":"Shock"},{"issue":"5","key":"6967_CR13","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1177\/1203475417712497","volume":"21","author":"RA Marrie","year":"2017","unstructured":"Marrie RA, Bernstein CN, Peschken CA et al (2017) Increased incidence of critical illness in psoriasis. J Cutan Med Surg 21(5):395\u2013400. https:\/\/doi.org\/10.1177\/1203475417712497","journal-title":"J Cutan Med Surg"},{"issue":"6","key":"6967_CR14","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1097\/MCG.0b013e318275d981","volume":"47","author":"C Ha","year":"2013","unstructured":"Ha C, Maser EA, Kornbluth A (2013) Clinical presentation and outcomes of inflammatory bowel disease patients admitted to the intensive care unit. J Clin Gastroenterol 47(6):485\u2013490. https:\/\/doi.org\/10.1097\/MCG.0b013e318275d981","journal-title":"J Clin Gastroenterol"},{"issue":"1","key":"6967_CR15","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1186\/s13054-015-0956-z","volume":"19","author":"HY van der Weide","year":"2015","unstructured":"van der Weide HY, van Westerloo DJ, van den Bergh WM (2015) Critical care management of systemic mastocytosis: when every wasp is a killer bee. Crit Care 19(1):238. https:\/\/doi.org\/10.1186\/s13054-015-0956-z","journal-title":"Crit Care"},{"key":"6967_CR16","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13054-016-1189-5","volume":"20","author":"A Kimmoun","year":"2016","unstructured":"Kimmoun A, Baux E, Das V et al (2016) Outcomes of patients admitted to intensive care units for acute manifestation of small-vessel vasculitis: a multicenter, retrospective study. Crit Care 20:27. https:\/\/doi.org\/10.1186\/s13054-016-1189-5","journal-title":"Crit Care"},{"key":"6967_CR17","unstructured":"Groh M, Clisson-Russek I, Rohmer J, et al. Hyper\u00e9osinophilies et syndromes hyper\u00e9osinophiliques (Protocole National de Diagnostic et de Soins). 2022. https:\/\/www.has-sante.fr\/upload\/docs\/application\/pdf\/2022-06\/pnds_she_document_complet.pdf"},{"issue":"5","key":"6967_CR18","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373\u2013383. https:\/\/doi.org\/10.1016\/0021-9681(87)90171-8","journal-title":"J Chronic Dis"},{"issue":"7","key":"6967_CR19","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/BF01709751","volume":"22","author":"JL Vincent","year":"1996","unstructured":"Vincent JL, Moreno R, Takala J et al (1996) The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction\/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 22(7):707\u2013710. https:\/\/doi.org\/10.1007\/BF01709751","journal-title":"Intensive Care Med"},{"issue":"5","key":"6967_CR20","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1111\/bjd.12501","volume":"169","author":"SH Kardaun","year":"2013","unstructured":"Kardaun SH, Sekula P, Valeyrie-Allanore L et al (2013) Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study. Br J Dermatol 169(5):1071\u20131080","journal-title":"Br J Dermatol"},{"key":"6967_CR21","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1111\/j.1365-2133.2007.08156.x","volume":"157","author":"A Sidoroff","year":"2007","unstructured":"Sidoroff A, Dunant A, Viboud C et al (2007) Risk factors for acute generalized exanthematous pustulosis (AGEP)-results of a multinational case-control study (EuroSCAR). Br J Dermatol 157:989\u2013996","journal-title":"Br J Dermatol"},{"issue":"20","key":"6967_CR22","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","volume":"127","author":"DA Arber","year":"2016","unstructured":"Arber DA, Orazi A, Hasserjian R et al (2016) The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 127(20):2391\u20132405. https:\/\/doi.org\/10.1182\/blood-2016-03-643544","journal-title":"Blood"},{"issue":"20","key":"6967_CR23","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","volume":"127","author":"SH Swerdlow","year":"2016","unstructured":"Swerdlow SH, Campo E, Pileri SA et al (2016) The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 127(20):2375\u20132390. https:\/\/doi.org\/10.1182\/blood-2016-01-643569","journal-title":"Blood"},{"issue":"1","key":"6967_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.37715","volume":"65","author":"JC Jennette","year":"2013","unstructured":"Jennette JC, Falk RJ, Bacon PA et al (2013) 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 65(1):1\u201311. https:\/\/doi.org\/10.1002\/art.37715","journal-title":"Arthritis Rheum"},{"issue":"6","key":"6967_CR25","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1164\/rccm.201710-1967CI","volume":"197","author":"FD Giacomi","year":"2018","unstructured":"Giacomi FD, Vassallo R, Yi ES, Ryu JH (2018) Acute eosinophilic pneumonia causes, diagnosis, and management. Poumon aigue Eo Am J Respir Crit Care Med 197(6):728\u2013736. https:\/\/doi.org\/10.1164\/rccm.201710-1967CI","journal-title":"Poumon aigue Eo Am J Respir Crit Care Med"},{"issue":"3","key":"6967_CR26","doi-asserted-by":"publisher","first-page":"e36","DOI":"10.1164\/rccm.202005-2032ST","volume":"202","author":"G Raghu","year":"2020","unstructured":"Raghu G, Remy-Jardin M, Ryerson CJ et al (2020) Diagnosis of hypersensitivity pneumonitis in adults. An official ATS\/JRS\/ALAT clinical practice guideline. Am J Respir Crit Care Med 202(3):e36\u2013e69. https:\/\/doi.org\/10.1164\/rccm.202005-2032ST","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"6967_CR27","doi-asserted-by":"publisher","first-page":"405","DOI":"10.7326\/0003-4819-86-4-405","volume":"86","author":"M Rosenberg","year":"1977","unstructured":"Rosenberg M, Patterson R, Mintzer R et al (1977) Clinical and immunologic criteria for the diagnosis of allergic bronchopulmonary aspergillosis. Ann Intern Med 86(4):405\u2013414. https:\/\/doi.org\/10.7326\/0003-4819-86-4-405","journal-title":"Ann Intern Med"},{"issue":"6","key":"6967_CR28","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","volume":"71","author":"JP Donnelly","year":"2020","unstructured":"Donnelly JP, Chen SC, Kauffman CA et al (2020) Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium. Clin Infect Dis 71(6):1367\u20131376. https:\/\/doi.org\/10.1093\/cid\/ciz1008","journal-title":"Clin Infect Dis"},{"issue":"9237","key":"6967_CR29","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/S0140-6736(00)02799-9","volume":"356","author":"IR Edwards","year":"2000","unstructured":"Edwards IR, Aronson JK (2000) Adverse drug reactions: definitions, diagnosis, and management. Lancet 356(9237):1255\u20131259. https:\/\/doi.org\/10.1016\/S0140-6736(00)02799-9","journal-title":"Lancet"},{"issue":"3","key":"6967_CR30","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1093\/biomet\/81.3.515","volume":"81","author":"PM Grambsch","year":"1994","unstructured":"Grambsch PM, Therneau TM (1994) Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 81(3):515\u2013526. https:\/\/doi.org\/10.1093\/biomet\/81.3.515","journal-title":"Biometrika"},{"issue":"1","key":"6967_CR31","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jaci.2010.04.011","volume":"126","author":"F Roufosse","year":"2010","unstructured":"Roufosse F, Weller PF (2010) Practical approach to the patient with hypereosinophilia. J Allergy Clin Immunol 126(1):39\u201344. https:\/\/doi.org\/10.1016\/j.jaci.2010.04.011","journal-title":"J Allergy Clin Immunol"},{"issue":"17","key":"6967_CR32","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1097\/MD.0000000000000088","volume":"93","author":"G Lef\u00e8vre","year":"2014","unstructured":"Lef\u00e8vre G, Copin MC, Staumont-Sall\u00e9 D et al (2014) The lymphoid variant of hypereosinophilic syndrome: study of 21 patients with CD3-CD4+ aberrant T-cell phenotype. Medicine (Baltimore) 93(17):255\u2013266. https:\/\/doi.org\/10.1097\/MD.0000000000000088","journal-title":"Medicine (Baltimore)"},{"issue":"11","key":"6967_CR33","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1002\/ajh.25945","volume":"95","author":"J Rohmer","year":"2020","unstructured":"Rohmer J, Couteau-Chardon A, Trichereau J et al (2020) Epidemiology, clinical picture and long-term outcomes of FIP1L1-PDGFRA-positive myeloid neoplasm with eosinophilia: data from 151 patients. Am J Hematol 95(11):1314\u20131323. https:\/\/doi.org\/10.1002\/ajh.25945","journal-title":"Am J Hematol"},{"issue":"11","key":"6967_CR34","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/S2213-2600(15)00367-7.E","volume":"3","author":"DB Price","year":"2015","unstructured":"Price DB, Rigazio A, Campbell JD et al (2015) Blood eosinophil count and prospective annual asthma disease burden: a UK cohort study. Lancet Respir Med 3(11):849\u2013858. https:\/\/doi.org\/10.1016\/S2213-2600(15)00367-7.E","journal-title":"Lancet Respir Med"},{"issue":"6","key":"6967_CR35","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/S2213-2600(15)00106-X","volume":"3","author":"S Pascoe","year":"2015","unstructured":"Pascoe S, Locantore N, Dransfield MT et al (2015) Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials. Lancet Respir Med 3(6):435\u2013442. https:\/\/doi.org\/10.1016\/S2213-2600(15)00106-X","journal-title":"Lancet Respir Med"},{"issue":"6","key":"6967_CR36","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1164\/ajrccm.160.6.9811041","volume":"160","author":"JJ Hospers","year":"1999","unstructured":"Hospers JJ, Schouten JP, St W et al (1999) Asthma attacks with eosinophilia predict mortality from chronic obstructive pulmonary disease in a general population sample. Am J Respir Crit Care Med 160(6):1869\u20131874. https:\/\/doi.org\/10.1164\/ajrccm.160.6.9811041","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"6967_CR37","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1093\/cid\/cit385","volume":"57","author":"L Grandi\u00e8re-P\u00e9rez","year":"2013","unstructured":"Grandi\u00e8re-P\u00e9rez L, Caumes E (2013) Corticosteroids for watershed infarction in acute schistosomiasis. Clin Infect Dis 57(6):918\u2013919. https:\/\/doi.org\/10.1093\/cid\/cit385","journal-title":"Clin Infect Dis"},{"issue":"3","key":"6967_CR38","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.12.009","volume":"26","author":"K Psychogios","year":"2017","unstructured":"Psychogios K, Evmorfiadis I, Dragomanovits S et al (2017) ANCA-negative Churg-Strauss syndrome presenting as acute multiple cerebral infarcts: a case report. J Stroke Cerebrovasc Dis 26(3):e47\u2013e49. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2016.12.009","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"9","key":"6967_CR39","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.autrev.2017.07.007","volume":"16","author":"R Andr\u00e9","year":"2017","unstructured":"Andr\u00e9 R, Cottin V, Saraux JL et al (2017) Central nervous system involvement in eosinophilic granulomatosis with polyangiitis (Churg-Strauss): report of 26 patients and review of the literature. Autoimmun Rev 16(9):963\u2013969. https:\/\/doi.org\/10.1016\/j.autrev.2017.07.007","journal-title":"Autoimmun Rev"},{"issue":"1\u20132","key":"6967_CR40","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.jns.2014.10.023","volume":"347","author":"D Lee","year":"2014","unstructured":"Lee D, Ahn TB (2014) Central nervous system involvement of hypereosinophilic syndrome: a report of 10 cases and a literature review. J Neurol Sci 347(1\u20132):281\u2013287. https:\/\/doi.org\/10.1016\/j.jns.2014.10.023","journal-title":"J Neurol Sci"},{"issue":"1","key":"6967_CR41","doi-asserted-by":"publisher","first-page":"6388","DOI":"10.1038\/s41598-021-85852-9","volume":"11","author":"V R\u00e9au","year":"2021","unstructured":"R\u00e9au V, Vall\u00e9e A, Terrier B et al (2021) Venous thrombosis and predictors of relapse in eosinophil-related diseases. Sci Rep 11(1):6388. https:\/\/doi.org\/10.1038\/s41598-021-85852-9","journal-title":"Sci Rep"},{"issue":"4","key":"6967_CR42","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1111\/bjh.12729","volume":"165","author":"S Todd","year":"2014","unstructured":"Todd S, Hemmaway C, Nagy Z (2014) Catastrophic thrombosis in idiopathic hypereosinophilic syndrome. Br J Haematol 165(4):425. https:\/\/doi.org\/10.1111\/bjh.12729","journal-title":"Br J Haematol"},{"issue":"3","key":"6967_CR43","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1093\/ckj\/sft046","volume":"6","author":"N Shehwaro","year":"2013","unstructured":"Shehwaro N, Langlois AL, Gueutin V, Izzedine H (2013) Renal involvement in idiopathic hypereosinophilic syndrome. Clin Kidney J 6(3):272\u2013276. https:\/\/doi.org\/10.1093\/ckj\/sft046","journal-title":"Clin Kidney J"},{"key":"6967_CR44","doi-asserted-by":"publisher","first-page":"b5087","DOI":"10.1136\/bmj.b5087","volume":"340","author":"LE L\u00e9vesque","year":"2010","unstructured":"L\u00e9vesque LE, Hanley JA, Kezouh A, Suissa S (2010) Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes. BMJ 340:b5087. https:\/\/doi.org\/10.1136\/bmj.b5087","journal-title":"BMJ"},{"issue":"24","key":"6967_CR45","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1001\/jama.270.24.2957","volume":"270","author":"JR Le Gall","year":"1993","unstructured":"Le Gall JR, Lemeshow S, Saulnier F (1993) A new Simplified Acute Physiology Score (SAPS II) based on a European\/North American multicenter study. JAMA 270(24):2957\u20132963. https:\/\/doi.org\/10.1001\/jama.270.24.2957","journal-title":"JAMA"},{"issue":"4","key":"6967_CR46","doi-asserted-by":"publisher","first-page":"R137","DOI":"10.1186\/cc8016","volume":"13","author":"PA Hampshire","year":"2009","unstructured":"Hampshire PA, Welch CA, McCrossan LA et al (2009) Admission factors associated with hospital mortality in patients with haematological malignancy admitted to UK adult, general critical care units: a secondary analysis of the ICNARC Case Mix Programme Database. Crit Care 13(4):R137. https:\/\/doi.org\/10.1186\/cc8016","journal-title":"Crit Care"},{"issue":"10","key":"6967_CR47","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1007\/s00134-021-06502-2","volume":"47","author":"BL Ferreyro","year":"2021","unstructured":"Ferreyro BL, Scales DC, Wunsch H et al (2021) Critical illness in patients with hematologic malignancy: a population-based cohort study. Intensive Care Med 47(10):1104\u20131114. https:\/\/doi.org\/10.1007\/s00134-021-06502-2","journal-title":"Intensive Care Med"},{"issue":"20","key":"6967_CR48","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1056\/NEJMoa1702079","volume":"376","author":"ME Wechsler","year":"2017","unstructured":"Wechsler ME, Akuthota P, Jayne D et al (2017) Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis. N Engl J Med 376(20):1921\u20131932. https:\/\/doi.org\/10.1056\/NEJMoa1702079","journal-title":"N Engl J Med"},{"issue":"12","key":"6967_CR49","doi-asserted-by":"publisher","first-page":"4431","DOI":"10.1016\/j.jaip.2021.07.050","volume":"9","author":"GJ Gleich","year":"2021","unstructured":"Gleich GJ, Roufosse F, Chupp G et al (2021) Safety and efficacy of mepolizumab in hypereosinophilic syndrome: an open-label extension study. J Allergy Clin Immunol Pract 9(12):4431-4440.e1. https:\/\/doi.org\/10.1016\/j.jaip.2021.07.050","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"9","key":"6967_CR50","doi-asserted-by":"publisher","first-page":"3529","DOI":"10.1016\/j.jaip.2021.06.047","volume":"9","author":"F Mesli","year":"2021","unstructured":"Mesli F, Dumont M, Soria A et al (2021) Benralizumab: a potential tailored treatment for life-threatening DRESS in the COVID-19 era. J Allergy Clin Immunol Pract 9(9):3529-3531.e1. https:\/\/doi.org\/10.1016\/j.jaip.2021.06.047","journal-title":"J Allergy Clin Immunol Pract"}],"updated-by":[{"DOI":"10.1007\/s00134-023-07059-y","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T00:00:00Z","timestamp":1681257600000}}],"container-title":["Intensive Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-022-06967-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00134-022-06967-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-022-06967-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T11:03:00Z","timestamp":1681297380000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00134-022-06967-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,1]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["6967"],"URL":"https:\/\/doi.org\/10.1007\/s00134-022-06967-9","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s00134-023-07059-y","asserted-by":"object"}]},"ISSN":["0342-4642","1432-1238"],"issn-type":[{"value":"0342-4642","type":"print"},{"value":"1432-1238","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,1]]},"assertion":[{"value":"29 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00134-023-07059-y","URL":"https:\/\/doi.org\/10.1007\/s00134-023-07059-y","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"GL: consulting fees from GlaxoSmithKline and AstraZeneca; JEK: consulting fees from GlaxoSmithKline and AstraZeneca; MG: consulting fees from GlaxoSmithKline and AstraZeneca.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}